ENVI Committee - Vote on a Pharmaceutical Strategy for Europe - Statement by Dolors MONTSERRAT

EP Plenary session - Pharmaceutical strategy for Europe

Custom officers with falsified medical products

Medecin - Health care - Medics - Medicine

Health Related Matters

The Environment and Public Health Committee adopt its position on the update of the EU Pharmaceutical Strategy. MEPs vote on a number of recommendations like establishing patient-centred health policies, supporting an innovative pharmaceutical industry. Other areas covered include and measures for more secure supply chains, sustainable medicines and crisis preparedness and response mechanisms.

Pharmaceutical Strategy for Europe: extract from the votes and statement by Dolors MONTSERRAT (EPP, ES), rapporteur - ENVI

During the remote plenary session (23-26/11/2020) of the European Parliament in Brussels, MEPs debate on a pharmaceutical strategy for Europe in the framework of the Covid-19 outbreak with Stella KYRIAKIDES, European Commissioner for Health and Food Safety. MEPs statements by Dolors MONTSERRAT (EPP, ES), Heléne FRITZON (S&D, SE), Kim VAN SPARRENTAK (Greens/EFA, NL), Frédérique RIES (RE, BE), Marc BOTENGA (GUE/NGL, BE).

Pharmaceutical strategy for Europe: extracts from the debate

During the plenary session of the European Parliament in Strasbourg, MEPs debate on pharmacovigilance.

3 találat